Tepadina (thiotepa) is a cytotoxic treatment for haematological disease and solid tumours. It is approved for use alongside other forms of chemotherapy in preparation for allogeneic or autologous haematopoietic progenitor cell transplantation.
Thiotepa acts as an alkylating agent. It has efficacy in a variety of malignancies, including lymphoma and myeloma, breast and ovarian cancer and tumours of the central nervous system and germ cells. Treatment must be supervised by a specialist.
Further information: Intrapharm